Physicochemical Properties
| Molecular Formula | C23H28BRN3O3 |
| Molecular Weight | 474.39 |
| Exact Mass | 473.131 |
| CAS # | 115338-32-4 |
| Related CAS # | NAN-190;102392-05-2 |
| PubChem CID | 107966 |
| Appearance | Light yellow to yellow solid powder |
| Boiling Point | 560.8ºC at 760mmHg |
| Flash Point | 293ºC |
| Vapour Pressure | 1.32E-12mmHg at 25°C |
| LogP | 3.792 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 7 |
| Heavy Atom Count | 30 |
| Complexity | 552 |
| Defined Atom Stereocenter Count | 0 |
| InChi Key | AXRUEPFPTQYHQD-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C23H27N3O3.BrH/c1-29-21-11-5-4-10-20(21)25-16-14-24(15-17-25)12-6-7-13-26-22(27)18-8-2-3-9-19(18)23(26)28;/h2-5,8-11H,6-7,12-17H2,1H3;1H |
| Chemical Name | 2-[4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl]isoindole-1,3-dione;hydrobromide |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| Targets | 5-HT1 Receptor |
| ln Vivo | The effective dose of fluoxetine is injected concurrently with NAN-190 hydrobromide (0.5 mg/kg, ip). In 6-OHDA lesioned rats, NAN-190 reverses the fluoxetine's catalepsy-improving effect[2]. |
| References |
[1]. Detection of phospholipidosis induction: a cell-based assay in high-throughput and high-content format. J Biomol Screen. 2014 Jan;19(1):66-76. [2]. Dose-Dependent Effect of Flouxetine on 6-OHDA-Induced Catalepsy in Male Rats: A Possible Involvement of 5-HT1A Receptors. Adv Pharm Bull. 2013;3(1):203-6. [3]. Antidepressant-like effect of Hoodia gordonii in a forced swimming test in mice: evidence for involvement of the monoaminergic system. Braz J Med Biol Res. 2015 Jan;48(1):57-64. |
| Additional Infomation |
NAN 190 hydrobromide is a hydrobromide obtained by reaction of NAN 190 with one equivalent of hydrobromic acid. It has a role as a serotonergic antagonist. It contains a NAN 190(1+). See also: Nan 190 (annotation moved to). |
Solubility Data
| Solubility (In Vitro) |
DMSO: 16.67 mg/mL (35.14 mM) H2O: < 0.1 mg/mL |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 1.67 mg/mL (3.52 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 16.7 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 1.67 mg/mL (3.52 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 16.7 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C，1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.1080 mL | 10.5399 mL | 21.0797 mL | |
| 5 mM | 0.4216 mL | 2.1080 mL | 4.2159 mL | |
| 10 mM | 0.2108 mL | 1.0540 mL | 2.1080 mL |